University Health Network
The Clinical Study and Regulatory Assistant role at the Princess Margaret Cancer Centre supports a large-scale Molecular Residual Disease (MRD) study by curating clinical data, maintaining study documentation, and coordinating regulatory submissions. The position involves accurate data entry, quality review, and collaboration with interdisciplinary teams to ensure compliant research conduct and high-quality genomic data generation.
University Health Network (UHN) is a Toronto-based academic health sciences centre that delivers acute, specialty and rehabilitative care while advancing medical research and education. UHN operates major hospitals and institutes including Toronto General, Toronto Western, Princess Margaret Cancer Centre and the Toronto Rehabilitation Institute, offering leading programs in transplantation, cardiac care, oncology, neuroscience and rehabilitation. Affiliated with the University of Toronto, it combines patient care, clinical trials and health‑system innovation to translate research into new therapies and practices. UHN serves local, regional and national patients and partners with public and private organizations to improve health outcomes and health‑care delivery.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for University Health Network.
Regulatory Operations Manager - Pediatrics
Dana-Farber Cancer Institute
Medical Director, Clinical Development – MRD Portfolio (Solid Tumors)
Labcorp
Clinical Research Coordinator III (Phase 1)
UNM Health System
Clinical Trial Coordinator
St Vincent's Hospital Melbourne
Study Start‑Up Lead
Roche
Global Development Medical Director, Hematology Oncology
AstraZeneca